These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38711374)

  • 1. Editorial: Hepatitis C virus eradication improves skeletal muscle mass.
    Tian CJL; Ngu JH
    Aliment Pharmacol Ther; 2024 Jun; 59(11):1446-1447. PubMed ID: 38711374
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Hepatitis C virus eradication improves skeletal muscle mass-Authors' reply.
    Coelho MPP; de Vries TP; Pires AM; Parreira MP; de Alvarenga ÉR; Cambraia RD; Dos Santos RR; Bezerra JMT; Colosimo EA; Rocha GA; Silva LD
    Aliment Pharmacol Ther; 2024 Jun; 59(11):1448-1450. PubMed ID: 38711360
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changing therapy against hepatitis C virus infection and issues after eradication of the virus].
    Chayama K
    Nihon Shokakibyo Gakkai Zasshi; 2021; 118(1):1-4. PubMed ID: 33431743
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current management of hepatitis C].
    Lange CM
    Med Monatsschr Pharm; 2015 Sep; 38(9):337-44; quiz 345-6. PubMed ID: 26731851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behind the Decrease of Liver Stiffness After Successful Hepatitis C Virus Eradication with Direct-Acting Antiviral Agents.
    Giuffrè M; Masutti F; Maria Crosato I; Luzzati R; Saveria Crocè L
    Turk J Gastroenterol; 2022 Feb; 33(2):169-170. PubMed ID: 35238783
    [No Abstract]   [Full Text] [Related]  

  • 6. Surveillance for hepatocellular carcinoma after hepatitis C virus eradication.
    Testino G
    Minerva Med; 2022 Jun; 113(3):569-570. PubMed ID: 32166937
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis.
    Sakamori R; Yamada R; Shinkai K; Doi A; Tahata Y; Shigekawa M; Kodama T; Hikita H; Yamada T; Tatsumi T; Takehara T
    Intern Med; 2021; 60(5):745-750. PubMed ID: 33642562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness and safety of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection].
    Yang J; Rao HY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):175-178. PubMed ID: 29804389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis C in 2020: from the therapeutic victory over the virus C to the effort on screening].
    Warling O; Delwaide J
    Rev Med Liege; 2020 May; 75(5-6):366-368. PubMed ID: 32496681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus therapeutics: at the end of the beginning.
    Schooley RT
    Top Antivir Med; 2012; 20(1):17-9. PubMed ID: 22538246
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiviral therapy of chronic hepatitis C: 30 years success story].
    Abdurakhmanov DT; Rozina TP; Nikulkina EN; Burnevich EZ; Tanashuk EL; Severov MV; Filatova AL; Milovanova SY; Karpov VV; Moiseev SV
    Ter Arkh; 2019 Nov; 91(11):110-115. PubMed ID: 32598621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Towards the eradication of hepatitis C virus.
    Marcellin P; Asselah T
    Liver Int; 2012 Feb; 32 Suppl 1():1. PubMed ID: 22212564
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct-acting antiviral treatments in Australia for children with chronic hepatitis C virus infection.
    Eldredge JA; Stormon MO; Clark JE; Nightingale S; McMullan B; Andersen B; Travers C; Hardikar W
    Med J Aust; 2023 Mar; 218(5):229-230. PubMed ID: 36794442
    [No Abstract]   [Full Text] [Related]  

  • 15. ANA, lupus and hepatitis C. Comment to "infection with hepatitis C virus, interferon α and lupus: an odd association".
    Martín-Gómez MA
    Nefrologia; 2015; 35(5):506-7. PubMed ID: 26388351
    [No Abstract]   [Full Text] [Related]  

  • 16. How to Optimize the Care Cascade of Hepatitis C Virus Infection.
    Kim BK
    Gut Liver; 2022 Nov; 16(6):809-810. PubMed ID: 36379904
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of dialysis patients with hepatitis C virus in the era of direct-acting antiviral therapy.
    Jadoul M; Labriola L
    Ther Apher Dial; 2024 Feb; 28(1):158-159. PubMed ID: 37667594
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatitis C virus ten years after its discovery].
    Bralet MP; Dhumeaux D; Zafrani ES
    Ann Pathol; 1999 Dec; 19(6):499-512. PubMed ID: 10617807
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial Commentary: Interferon-free Hepatitis C Treatment Efficacy From Clinical Trials Will Translate to "Real World" Outcomes.
    Martinello M; Dore GJ
    Clin Infect Dis; 2016 Apr; 62(7):927-8. PubMed ID: 26743092
    [No Abstract]   [Full Text] [Related]  

  • 20. Authors response to Management of dialysis patients with hepatitis C virus in the era of direct-acting antiviral therapy.
    Toyoda H; Kikuchi K
    Ther Apher Dial; 2024 Feb; 28(1):160-161. PubMed ID: 37771101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.